N@N

CPHD, CALP, ANF, CODE, MET, ITMN, Expected to Trade Lower After Bearish Insider Trading

^{Published on 2011-06-15 06:20:30 - WOPRAI}
 

June 15, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. CEPHEID (NASDAQ:CPHD), CALIPER LIFE SCIENCES, INC. (NASDAQ:CALP), ABERCROMBIE & FITCH CO (NYSE:ANF), SPANSION INC (NYSE:CODE), METLIFE, INC. (NYSE:MET), INTERMUNE, INC. (NASDAQ:ITMN) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     CPHD       CEPHEID                             Persing, David H                    CT          70,000         92                -33.4%                 9         
     CALP       CALIPER LIFE SCIENCES, INC.         Manyak, David M                     O           25,000         90                -20.6%                 12        
     ANF        ABERCROMBIE & FITCH CO              Jeffries, Michael S                 CEO         100,000        91                -8.9%                  56        
     CODE       SPANSION INC                        Nawaz, Ahmed                        O           5,982          98                -62.8%                 21        
     MET        METLIFE, INC.                       Henrikson, C Robert                 CB          20,000         97                -28.1%                 17        
     ITMN       INTERMUNE, INC.                     Simon, Howard Allan                 O           30,754         95                -34.8%                 7         

CEPHEID (NASDAQ:CPHD) - Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical market, as well as for application in legacy biothreat, industrial, and partner markets. Its systems enable molecular testing for organisms and genetic-based diseases by automation. The company offers SmartCycler system that integrates DNA amplification and detection to allow rapid analysis of a sample; and GeneXpert system that integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for reference laboratories, hospital central laboratories, and satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors offices. It also provides GeneXpert Infinity System for high volume testing. The company offers tests for the GeneXpert and the SmartCycler systems in the areas of healthcare associated infections, critical infectious disease, genetics, womens health, and oncology. These tests include in vitro diagnostic medical devices, CE marked products, analyte specific reagents, and research use only tests. In the industrial market, it sells its SmartCycler system along with general use polymerase chain reaction reagents and reaction tubes. The company also offers tests for anthrax, pestis, and tullarensis in the biothreat market. Cepheid sells its products through direct sales and distribution channels worldwide. It has strategic commercial relationship with bioMerieux, Inc. for bioMerieux to develop DNA testing products using nucleic acid sequence-based amplification technology; and a collaboration agreement with Foundation for Innovative New Diagnostics for the development of a rapid molecular test for the measurement of human immunodeficiency virus viral load. The company was founded in 1996 and is based in Sunnyvale, California.

CALIPER LIFE SCIENCES, INC. (NASDAQ:CALP) - Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide. Its integrated systems consist of instruments, software and reagents, laboratory automation tools, and assay and discovery services. The company offers a portfolio of molecular imaging, microfluidics, automation and liquid handling technologies, and scientific applications to address various limitations in the drug discovery and development process. Its products include IVIS Imaging Systems and Living Image Software, an integrated optical molecular imaging solution; Light-Producing Cells and Microorganisms to analyze the spread and treatment of cancer and infectious diseases, as well as to study immunology; Light Producing Transgenic Animal models to analyze gene expression, protein activity, and disease progression; and luciferin, a chemical compound to produce bioluminescence, and VivoFluor fluorescent labeling kits for fluorescent imaging. The companys products also comprise LabChip GX series of instruments targeted at genomics applications; LabChip EZ Reader, EZ Reader II, and ProfilerPro Kits; Caliper Sciclone that incorporates automated microplate carriers; Zephyr, a liquid handling instrument; staccato automated workstations for drug discovery, genomics, proteomics, and drug development laboratories; Twister I and II, which automate the movement of microplates; TurboVap family of evaporators; and RapidTrace solid phase extraction workstation. In addition, it offers contract research services, drug discovery and development services, alliances and integrated research programs, environmental testing, and product support services. Caliper Life Sciences sells its products through direct sales force, a network of distributors, partnership channels, and joint marketing agreements. The company was founded in 1995 and is headquartered in Hopkinton, Massachusetts.

ABERCROMBIE & FITCH CO (NYSE:ANF) - Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer of casual apparel for men, women, and kids. The company sells casual sportswear apparel, including knit and woven shirts, graphic t-shirts, fleece, jeans and woven pants, shorts, sweaters, and outerwear; personal care products; and accessories under the Abercrombie & Fitch, abercrombie kids, and Hollister brands. It also offers bras, underwear, sleepwear, and at-home products for girls under the Gilly Hicks brand. The company sells products through its stores; direct-to-consumer operations; and Websites, which comprise abercrombie.com, abercrombiekids.com, hollisterco.com, and gillyhicks.com. As of January 29, 2011, it operated 1,069 stores in North America, Europe, and Japan. The company was founded in 1892 and is headquartered in New Albany, Ohio.

SPANSION INC (NYSE:CODE) - Spansion Inc., a semiconductor device company, engages in designing, developing, manufacturing, marketing, and selling NOR flash memory solutions worldwide. The companys products are designed primarily to store microprocessor instructions or code and data in embedded applications; and execution is based on NOR Flash memory architecture and utilize traditional floating gate technology or MirrorBit technology. Its flash memory products are used in a range of applications, including automotive electronics, such as navigation systems and engine control; PC and peripheral computing equipment comprising printers; consumer equipment, such as set top boxes and home networking; communication equipment that consists of enterprise networking and cellular infrastructure; arcade gaming equipment; industrial control equipment; and mobile phones. Spansion markets and sells its products directly or through third-party distributors to original equipment manufacturers, original design manufacturers, and contract manufacturers. The company is headquartered in Sunnyvale, California.

METLIFE, INC. (NYSE:MET) - MetLife, Inc., through its subsidiaries, provides insurance, employee benefits, and financial services in the United States, Latin America, the Asia Pacific, Europe, the Middle East, and India. It offers group life insurance products and services as employer-paid benefits, including variable life, universal life, and term life products, as well as employee paid supplemental life products; individual life insurance products and services comprising variable life, universal life, term life, and whole life products, as well as a range of mutual funds and other securities products; and non-medical health insurance products and services, such as dental insurance, group short- and long-term disability, individual disability income, long-term care, critical illness, and accidental death and dismemberment coverages, as well as employer-sponsored auto and homeowners insurance and administrative services-only arrangements to employers. The company also provides retirement products consisting of variable and fixed annuities for individuals and employees of corporations, and other institutions. In addition, MetLife provides an array of annuity and investment products, including guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets, as well as offers certain products to fund postretirement benefits. Further, it offers auto insurance and homeowners insurance policies, as well as personal excess liability and coverage for recreational vehicles and boat owners; and credit insurance and endowment products. Additionally, the company funds company initiatives, various start-up entities, and run-off entities; and banking services, such as residential mortgage loans and various deposit products. The company was founded in 1868 and is based in New York, New York.

INTERMUNE, INC. (NASDAQ:ITMN) - InterMune, Inc., a biotech company, focuses on developing and commercializing therapies in pulmonology and hepatology primarily in the United States and Europe. The company primarily offers Actimmune for the treatment of patients with severe, malignant osteopetrosis, and chronic granulomatous disease. Its pulmonology product portfolio includes lead product candidate, pirfenidone, a phase III product being developed for the treatment of patients with idiopathic pulmonary fibrosis; and a research program focused on small molecules for pulmonary diseases. The companys hepatology portfolio comprises the HCV protease inhibitor RG7227, a phase IIb chronic hepatitis C program and an early stage research program evaluating a new target in hepatology. It has license and collaboration agreements with Genentech, Inc.; Boehringer Ingelheim International GmbH; Connetics Corporation; and Novartis Corporation. The company was founded in 1998 and is headquartered in Brisbane, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net